Newron Pharmaceuticals Statistics

Total Valuation

NWPHF has a market cap or net worth of 173.70 million. The enterprise value is 220.37 million.

Market Cap	173.70M
Enterprise Value	220.37M

Important Dates

The next estimated earnings date is Tuesday, September 16, 2025.

Earnings Date	Sep 16, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	19.06M
Shares Outstanding	n/a
Shares Change (YoY)	+15.30%
Shares Change (QoQ)	+21.68%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	18.88M

Valuation Ratios

The trailing PE ratio is 10.59.

PE Ratio	10.59
Forward PE	n/a
PS Ratio	3.26
PB Ratio	115.07
P/TBV Ratio	115.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.28, with an EV/FCF ratio of -12.08.

EV / Earnings	13.44
EV / Sales	3.73
EV / EBITDA	7.28
EV / EBIT	7.33
EV / FCF	-12.08

Financial Position

The company has a current ratio of 2.60, with a Debt / Equity ratio of 34.62.

Current Ratio	2.60
Quick Ratio	2.42
Debt / Equity	34.62
Debt / EBITDA	1.91
Debt / FCF	-2.86
Interest Coverage	6.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	36.44%
Return on Invested Capital (ROIC)	46.45%
Return on Capital Employed (ROCE)	64.78%
Revenue Per Employee	2.42M
Profits Per Employee	745,560
Employee Count	22
Asset Turnover	1.14
Inventory Turnover	n/a

Taxes

In the past 12 months, NWPHF has paid 5.75 million in taxes.

Income Tax	5.75M
Effective Tax Rate	25.95%

Stock Price Statistics

The stock price has increased by +25.65% in the last 52 weeks. The beta is 0.72, so NWPHF's price volatility has been lower than the market average.

Beta (5Y)	0.72
52-Week Price Change	+25.65%
50-Day Moving Average	9.36
200-Day Moving Average	9.35
Relative Strength Index (RSI)	37.60
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NWPHF had revenue of 53.20 million and earned 16.40 million in profits. Earnings per share was 0.80.

Revenue	53.20M
Gross Profit	53.20M
Operating Income	27.10M
Pretax Income	22.15M
Net Income	16.40M
EBITDA	27.12M
EBIT	27.10M
Earnings Per Share (EPS)	0.80

Full Income Statement

Balance Sheet

The company has 10.17 million in cash and 52.25 million in debt, giving a net cash position of -42.08 million.

Cash & Cash Equivalents	10.17M
Total Debt	52.25M
Net Cash	-42.08M
Net Cash Per Share	n/a
Equity (Book Value)	1.51M
Book Value Per Share	0.08
Working Capital	38.93M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.24 million and capital expenditures -13,459, giving a free cash flow of -18.25 million.

Operating Cash Flow	-18.24M
Capital Expenditures	-13,459
Free Cash Flow	-18.25M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 50.93% and 30.83%.

Gross Margin	100.00%
Operating Margin	50.93%
Pretax Margin	41.63%
Profit Margin	30.83%
EBITDA Margin	50.98%
EBIT Margin	50.93%
FCF Margin	n/a

Dividends & Yields

NWPHF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.30%
Shareholder Yield	n/a
Earnings Yield	9.44%
FCF Yield	-10.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NWPHF has an Altman Z-Score of 4.65 and a Piotroski F-Score of 4.

Altman Z-Score	4.65
Piotroski F-Score	4